InsiderTrades

Form 4 for PTCT PTC THERAPEUTICS, INC.

Accepted 2023-03-29 00:00:00 ET · period of report 2023-03-27 · accession 0001415889-23-005565 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-29 2023-03-27 PTCT SOUTHWELL DAVID P Dir S - Sale+OE $45.09 -10.0K 10.6K -49% -$450.9K
D 2023-03-29 2023-03-27 PTCT SOUTHWELL DAVID P Dir M - OptEx $27.05 +10.0K 20.5K +95% +$270.5K
D 2023-03-29 2023-03-27 PTCT SOUTHWELL DAVID P Dir M - OptEx $27.05 -10.0K 0 -100% -$270.5K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-27 S D 4,599 $44.71 15,901 D — — (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $43.97 to $44.95 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2023-03-27 M A 10,000 $27.05 20,500 D — —
3 Common Common Stock 2023-03-27 S D 100 $46.03 10,500 D — —
4 Common Common Stock 2023-03-27 S D 5,301 $45.41 10,600 D — — (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.00 to $45.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
5 Derivative Stock Option (Right to Buy) 2023-03-27 M D 10,000 $27.05 0 D $27.05 · — to 2024-01-28 10,000 Common Stock (F4) Currently exercisable.